findmyKOL
Clinical trialNCT07281027Not, yet, recruitingPhase 3Interventional

COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

SponsorYale UniversityEnrollment438Febrile Infection-Related Epilepsy Syndrome (FIRES)New Onset Refractory Status EpilepticusNew-Onset Refractory Status Epilepticus
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Western University

    London, Canada

  • Hospital for Sick Children

    Toronto, Canada

France
  • Salpêtrière

    Paris, France

Italy
  • University of Modena

    Modena, Italy

South Korea
  • Seoul National University Hospital

    Seoul, South Korea

Sweden
  • Karolinska Institute

    Stockholm, Sweden

United Kingdom
  • Great Ormond Street Hospital

    London, United Kingdom

  • King'S College

    London, United Kingdom

United States
  • Barrow Institute

    Phoenix, Arizona, United States

  • Children'S Hospital Colorado

    Aurora, Colorado, United States

  • Yale New Haven Hospital

    New Haven, Connecticut, United States

  • Children'S National (dc)

    Washington D.C., District of Columbia, United States

  • University of Florida

    Gainesville, Florida, United States

  • University of Chicago

    Chicago, Illinois, United States

  • Northwestern University

    Evanston, Illinois, United States

  • Beth Israel Deaconess

    Boston, Massachusetts, United States

  • Boston Children'S Hospital

    Boston, Massachusetts, United States

  • Mass General (mgh)

    Boston, Massachusetts, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • University of Nebraska

    Lincoln, Nebraska, United States

  • Columbia University

    New York, New York, United States

  • Mount Sinai (ny)

    New York, New York, United States

  • New York University

    New York, New York, United States

  • University of Cincinnati

    Cincinnati, Ohio, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Oregon Health and Science University

    Portland, Oregon, United States

  • Children'S Hospital Philadelphia (chop)

    Philadelphia, Pennsylvania, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Ut Southwestern Medical Center

    Dallas, Texas, United States

  • Baylor/texas Children'S

    Houston, Texas, United States

  • Seattle Children'S Hospital

    Seattle, Washington, United States

  • University of Wisconsin

    Madison, Wisconsin, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jul 2026
Primary completion
31 Mar 2030
Completion
30 Sept 2030
Last update posted
12 May 2026
Registered enrollment
438
Registry id
NCT07281027

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.